Agriculture & Agritech Global On demand · 24-48h

Global RNAi-Based Biocontrol Products Market Strategic Research Report

Global RNAi-Based Biocontrol Products Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global RNAi-Based Biocontrol Products Market
$1342025
8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: PIP, Non-PIP

By Application: Farmland, Orchard, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Bayer, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 94 pages
Market size 2025
$134
Million USD
Forecast CAGR
8%
2025-2032
Forecast 2032
$229.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global RNAi-Based Biocontrol Products market size is predicted to grow from US$ 134 million in 2025 to US$ 231 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032.

RNAi-based biocontrol products are biological crop protection inputs that use RNA interference (RNAi) to silence essential genes in target pests or pathogens, thereby delivering control efficacy. Commercial formats include plant-incorporated protectants (PIP), where crops express specific RNA for in-plant protection, and non-PIP products, where dsRNA or short RNA actives are formulated for foliar spray and, in some cases, soil or chemigation delivery. Key upstream elements include nucleotide and enzyme or fermentation inputs for manufacturing (via in vitro transcription or fermentation-based expression), formulation carriers and adjuvant systems (encapsulation, controlled release, uptake enhancers, UV and rainfast stabilizers), QC analytics, packaging, and temperature-managed or ambient logistics solutions; cost and supply capability are mainly driven by scalable manufacturing, unit-cost reduction, and improved field stability. Major downstream customers include crop protection companies and formulators, seed companies for PIP pathways, large growers and grower groups, ag input distributors and retailers, and public programs in selected pest scenarios. Applications span broadacre crops, orchards, and protected horticulture, often positioned within IPM programs and resistance-management rotations. On an ex-works manufacturing basis, gross margins typically fall in the 30% to 50% range, shaped by production route, carrier system and QC standards, registered use patterns, and channel and service intensity; as scaling improves and manufacturing costs decline, margins may stabilize, while uncertainty remains around field delivery efficiency, persistence, and regulatory timelines.

Global key RNAi-Based Biocontrol Products players cover Bayer, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, etc.

This report presents a comprehensive overview of the global RNAi-Based Biocontrol Products market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • PIP
  • Non-PIP

Segment by Target Organism

  • Insect Pests
  • Nematodes and Mites
  • Pathogens
  • Other

Segment by Application

  • Farmland
  • Orchard
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global RNAi-Based Biocontrol Products market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Farmland, Orchard, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global RNAi-Based Biocontrol Products Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$134
2025
Forecast
$229.7
2032
CAGR
8%
2025–2032
Regions
5
global
Key companies
BayerCortevaGreenlight BiosciencesRNAissance AgPebble LabsRenaissance BioScienceSilicon GeneShanghai Plant Science Biotechnology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PIPNon-PIP
By Application
FarmlandOrchardOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 PIP
  • 3.1.3 Non-PIP
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Farmland
  • 4.1.3 Orchard
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Bayer
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Corteva
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Greenlight Biosciences
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 RNAissance Ag
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Pebble Labs
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Renaissance BioScience
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Silicon Gene
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shanghai Plant Science Biotechnology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Xiaomo Biotech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global RNAi-Based Biocontrol Products market size?
The global RNAi-Based Biocontrol Products market is estimated at US$ 134 million in 2025 (base year) and is projected to reach US$ 231 million by 2032.
What growth rate is expected for the RNAi-Based Biocontrol Products market through 2032?
The market is expected to grow at a CAGR of 8.0% from 2026 to 2032, expanding from US$ 134 million in 2025 to US$ 231 million in 2032, roughly 1.7 times its base-year value.
How is RNAi-Based Biocontrol Products defined?
RNAi-based biocontrol products are biological crop protection inputs that use RNA interference (RNAi) to silence essential genes in target pests or pathogens, thereby delivering control efficacy. Commercial formats include plant-incorporated protectants (PIP), where crops express specific RNA for in-plant protection, and non-PIP products, where dsRNA or short RNA actives are formulated for foliar spray and, in some cases, soil or chemigation delivery.
What are the main segments of the RNAi-Based Biocontrol Products market by type?
By type, the market is segmented into PIP and Non-PIP.
Which applications drive demand in the RNAi-Based Biocontrol Products market?
Key applications covered include Farmland, Orchard and Other.
Who are the key players in the RNAi-Based Biocontrol Products market?
Key players profiled include Bayer, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, Silicon Gene and Shanghai Plant Science Biotechnology, among 9 companies covered in total.
Which regions and countries are covered for RNAi-Based Biocontrol Products?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the RNAi-Based Biocontrol Products market report?
The report is intended for manufacturers and solution providers, distributors and end users in Farmland, Orchard and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the RNAi-Based Biocontrol Products market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.